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Abstract
The normal cellular organization and layering of the vertebrate cerebellum is established during embryonic and early
postnatal development by the interplay of a complex array of genetic and signaling pathways. Disruption of these processes
and of the proper layering of the cerebellum usually leads to ataxic behaviors. Here, we analyzed the relative contribution of
Fibroblast growth factor receptor 2 (FGFR2)-mediated signaling to cerebellar development in conditional Fgfr2 single
mutant mice. We show that during embryonic mouse development, Fgfr2 expression is higher in the anterior cerebellar
primordium and excluded from the proliferative ventricular neuroepithelium. Consistent with this finding, conditional Fgfr2
single mutant mice display the most prominent defects in the anterior lobules of the adult cerebellum. In this context,
FGFR2-mediated signaling is required for the proper generation of Bergmann glia cells and the correct positioning of these
cells within the Purkinje cell layer, and for cell survival in the developing cerebellar primordium. Using cerebellar
microexplant cultures treated with an FGFR agonist (FGF9) or antagonist (SU5402), we also show that FGF9/FGFR-mediated
signaling inhibits the outward migration of radial glia and Bergmann glia precursors and cells, and might thus act as a
positioning cue for these cells. Altogether, our findings reveal the specific functions of the FGFR2-mediated signaling
pathway in the generation and positioning of Bergmann glia cells during cerebellar development in the mouse.
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Introduction
During vertebrate development, the cerebellum is folded into
lobes and lobules with a well-defined cellular architecture
comprising three cell layers, namely the outer molecular layer
(ML), the Purkinje cell layer (PCL) containing Purkinje cells (PCs)
and Bergmann glia (BG), and the granular layer (GL) made up of
granule cells (GCs) [1,2]. The aberrant generation during
embryonic development or degeneration during adulthood of
these main cerebellar layers and cell types can cause ataxic
behaviors, thus underscoring the essential role of the cerebellum
for motor coordination in vertebrates [3]. At around embryonic
day (E) 9.0 in mice, the cerebellar anlage (CbA) is specified in the
dorsal part of the anterior hindbrain under the influence of the
isthmic organizer located at the boundary between the midbrain
and the hindbrain [4,5]; reviewed by [1,2,6]. Shortly after, at
around E10–E12.5, neurons of the deep cerebellar nuclei are
among the first cells generated in the CbA [7,8]. Between E10 and
E13, PCs are born in the cerebellar ventricular zone (VZ) lining
the fourth ventricle, and migrate radially into the CbA along radial
glia (RG) fibers spanning from the ventricular to the pial surface of
the CbA [7,9–12]. PCs accumulate in a multilayer underlying a
second germinal zone in the outer CbA (the external granular
layer (EGL)) and later form a monolayer, the PCL, in the adult
cerebellar cortex. The EGL consists of granule cell precursors
(GCPs) deriving from the rhombic lip at around E12 and
migrating tangentially over the CbA surface until approx. E16
in mice [7,11]. BG precursors are born in the cerebellar VZ at
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around E13, and migrate radially into the CbA from E14 onwards
to settle among the PCs in the PCL [13]. Around birth, GCPs
begin to generate postmitotic GCs that migrate along the unipolar
fibers of mature BG cells past the PCs to the internal granular
layer (IGL), giving rise to the GL of the adult cerebellum. The ML,
containing postnatally born stellate and basket interneurons and
BG fibers ensheathing the GC axons and PC dendrites, is
established as the outer layer of the adult cerebellum when the
inward migration of GCs has ceased [1,2].
The Sonic hedgehog (SHH) and Fibroblast growth factor (FGF)
signaling pathways play a particularly prominent role during
cerebellar development. SHH secreted from PCs controls the
proliferation and subsequent differentiation of GCPs [14–18]. The
specific functions of the FGF/FGF receptor (FGFR) signaling
pathway(s), by contrast, still remain unclear due to the overlapping
expression domains of several FGFs and of the four known FGFRs
in the developing cerebellum [19], and because of the multiple
postnatal cerebellar defects in the corresponding mouse mutants
[20–22]. Conditional ablation of the Fgf9 or Fgfr1/Fgfr2 gene(s) in
neural progenitors and RG cells results in similar postnatal
cerebellar phenotypes [20,21], suggesting that FGF9 is one of the
principal FGFR1/FGFR2 ligands in the developing cerebellum.
In other cellular contexts, neuron-derived FGF9 binds to FGFR2
expressed on glial cells and acts as a potent survival factor [23–26].
We show here that the transcription of Fgfr2 within the
developing CbA initiates after E14.5 and comprises mostly cells
within the anterior CbA of the developing mouse embryo.
Conditional ablation of Fgfr2 in neural progenitors results in a
strong reduction of FGF signaling, in a reduced generation of BG
cells and their aberrant positioning within the EGL, and in a
decreased cell survival in the anterior CbA, leading to BG and PC
defects already during prenatal cerebellar development. We also
show that FGF9/FGFR2-mediated signaling inhibits the outward
migration of RG/BG cells in vitro, and might thereby control their




Generation and genotyping of Fgfr2lox/lox, Nestin-Cre and R26R
mice was described previously [27–29]. Mice were kept on mixed
(C57BL/6J, CD-1 and 129Sv) genetic backgrounds. CD-1 mice
were purchased from Charles River (Kisslegg/Germany). Nestin-
Cre mice were mated to Fgfr2lox/lox mice and the resulting Nestin-
Cre;Fgfr2+/lox and Fgfr2+/lox offspring was intercrossed to obtain
Nestin-Cre;Fgfr2lox/lox animals, which were maintained by mating to
Fgfr2lox/lox mice. Adult (2–7 months old) Nestin-Cre;Fgfr2lox/lox mice
(n = 25 for histological analysis) were compared to their Fgfr2lox/lox
littermate controls (n = 17 for histological analysis). For embryonic
analyses, Fgfr2lox/lox;R26R/R26R females were mated to Nestin-
Cre;Fgfr2+/lox males, and the Nestin-Cre;Fgfr2lox/lox;R26R/+ mutant
offspring (n = 28) was compared to Nestin-Cre;Fgfr2+/lox;R26R/+
heterozygote controls (n = 12). The CbA phenotype of the
analyzed Nestin-Cre;Fgfr2lox/lox;R26R/+ mutants was routinely
checked by in situ hybridization of serial sections from these
embryos with a Tenascin C (Tnc) riboprobe. Collection of
embryonic stages was done from timed-pregnant females, noon
of the day of vaginal plug detection was designated as E0.5. This
study was carried out in strict accordance with the recommenda-
tions in the Guide for the Care and Use of Laboratory Animals of
the European Union and of the Federal Republic of Germany
(TierSchG). The protocol was approved by the Institutional
Animal Care and Use Committee (Ausschuss fu¨r Tierversuche und
Versuchstierhaltung, ATV) of the Helmholtz Zentrum Mu¨nchen.
All efforts were made to minimize suffering.
Behavioral tests
12 weeks old male Nestin-Cre;Fgfr2lox/lox (n = 12) and Fgfr2lox/lox
control (n = 15) mice were tested in the modified hole board as
described previously [30]. Motor coordination and balance was
assessed one week later using the rotating rod apparatus (Rotarod
Letica LE 8200, Bioseb/France). The test phase consisted of three
trials separated by 15 min intertrial intervals. Per trial, three mice
were placed on the rod leaving an empty lane between two mice.
The rod was initially rotating at 4 rpm constant speed to allow
positioning of all mice in their respective lanes. Once all mice were
positioned, the rod accelerated from 4 to 40 rpm in 300 s, and
passive rotations or latency and rpm at which each mouse fell off
the rod were recorded.
EdU treatments
Pregnant dams were injected intraperitoneally with 10 mg 5-
ethynyl-29-deoxyuridine (EdU; Invitrogen/Germany) per gram
body weight on E17.5. Embryos were dissected 24 h later and
processed for EdU detection on paraffin sections according to the
manufacturer’s instructions (Click-iT EdU Alexa Fluor 488
Imaging Kit, Invitrogen).
Radioactive in situ hybridization (ISH)
Serial paraffin sections (8 mm) from embryonic and adult mouse
heads or brains were hybridized with radioactive ([a-35S]UTP, GE
Healthcare/USA) or Digoxigenin (DIG RNA Labeling Mix,
Roche/Germany) labeled riboprobes as described previously [31–
33]. Riboprobes used were Fgfr2 exon 5 and Etv5 (Erm) [27], Gad2
(GAD65) and VAChT (Slc18a3) [34], Fgfr1, Fgfr2, Fgfr3 and Fgfr4
[35], Tenascin C (Tnc) [36], Atoh1 (Math1) [37], Th and Sert (Slc6a4)
[31], Shh [38], and Patched 1 (Ptch1) [39]. Images were taken with
an Axioplan2 microscope or StemiSV6 stereomicroscope using
bright- and darkfield optics, AxioCam MRc camera and
Axiovision 4.6 software (Zeiss/Germany), and processed with
Adobe Photoshop CS5 software (Adobe Systems Inc./USA).
Immunohisto-/cytochemistry (IHC/ICC)
Antigens were detected on paraffin sections (8 mm), free-floating
cryosections (40 mm), or microexplant cultures as reported by
[31,40,41]; minor modifications are available upon request.
Primary antibodies used were mouse anti-Gfap (glial fibrillary
acidic protein) (1:1000; Sigma/Germany), anti-Calb1 (calbindin)
(1:200; Swant/Switzerland, CB300), anti-Blbp (Brain lipid binding
protein, Fabp7) (1:300; Millipore/USA) and anti-Pax6 (1:400;
Developmental Studies Hybridoma Bank/USA); rabbit anti-Calb2
(calretinin) (1:2000; Swant), anti-S100b (1:1000; Sigma), anti-
Calb1 (1:5000 (embryos), 1:2000 (adult tissues); Swant, CB38a),
anti-Ccnd1 (Cyclin D1) (1:150; Thermo Fisher Scientific/USA),
anti-Glast (Glial high affinity glutamate transporter, Slc1a3, Eaat1)
(1:100; Abcam/UK), anti-phosphorylated Histone H3 (pH3)
(1:1000; Millipore) and anti-cleaved (activated) Caspase 3 (cCasp3)
(1:150; Cell Signaling Technologies/USA); and goat anti-Sox2
(1:500; Santa Cruz Biotechnology/USA). Secondary antibodies
were either fluorescently labeled conjugates (AlexaFluor 488/546/
594, 1:500; Invitrogen) counterstained with 49,6-diamidino-2-
phenylindole (DAPI), or coupled to horseradish peroxidase and
detected using the Vectastain ABC Elite Kit (Vector Laboratories/
USA). Images were taken with an Axiovert 200M or Axioplan 2
microscope and AxioCam HRc or MRc camera (Zeiss), or with an
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Olympus IX81 confocal laser scanning microscope (Olympus/
Germany), and processed with Adobe Photoshop CS5 software.
Cell countings
Cells were counted in an area corresponding to approx. the
anterior part (anterobasal lobe) of the CbA on 5 to 8 midsagittal
sections from E16.5 and E18.5 control and Nestin-Cre;Fgfr2lox/lox;
R26R/+ embryos using Stereo Investigator 5.05.4 software (MBF
Bioscience/USA). Tnc (Tnc+) and cCasp3 (cCasp3+) -expressing cells
were normalized to this area (except the EGL area for cCasp3+ cells);
Pax6 (Pax6+) and EdU (EdU+) -expressing cells were normalized to
the Pax6+ EGL area; and pH3 (pH3+) -expressing cells were
normalized to the VZ area of the cerebellum.
Western blot
Brain tissues were isolated from 8 weeks old Fgfr2lox/lox (control),
heterozyote Nestin-Cre;Fgfr2+/lox and homozygote Nestin-Cre;Fgfr2lox/lox
mice, and homogenized in RIPA buffer (50 mM Tris-HCl pH 7.4,
150 mM NaCl, 1% NP-40, 0.25% Sodium deoxycholate, 1 mM
EDTA, and Complete protease inhibitors (Roche)). Total protein
concentration was determined with the Pierce BCA Protein Assay
(Thermo Fisher Scientific), and 50 mg total protein per sample were
separated in 10% NuPAGE Novex precast gels (Invitrogen) and
blotted onto PVDF membranes (Hall/USA). Blots were blocked in
4% skim milk in TBST (50 mM Tris-HCl pH 7.5, 150 mM NaCl,
0.05% Tween 20) and probed with rabbit anti-Fgfr2 (1:300; sc-122)
and anti-hypoxanthine guanine phosphoribosyl transferase (Hprt)
(1:400; FL-218) antibodies (both from Santa Cruz Biotechnology).
Membranes were developed in ECL substrate and exposed to
Hyperfilm ECL (GE Healthcare).
CbA microexplant cultures
CbA microexplant cultures were prepared essentially as
described by Kunemund et al. (1988) [42], with some modifica-
tions to account for the embryonic tissues and the smaller size of
the CbA. Briefly, cerebellar primordia were isolated from E16.5
CD-1 embryos, cut into small pieces of equal size (approx. 750 mm
diameter), and plated onto poly-D-lysine (50 mg/ml; Millipore)
and laminin (2 mg/ml; Roche) coated coverslips (1 microexplant/
coverslip) in Neurobasal medium supplemented with 2 mM L-
glutamine, 1x B27 nutrient mixture, 100 Units/ml penicillin,
100 mg/ml streptomycin (all from Invitrogen), and 200 nM
ascorbic acid (Sigma). Immediately after plating, 100 ng/ml
recombinant human FGF9 protein (R&D Systems/USA) in
bovine serum albumin (BSA), 20 mM InSolution SU5402 (Merck
Chemicals/Germany) in dimethyl sulfoxide (DMSO) or 0.0001%
BSA and 0.1% DMSO (control) were added to the medium.
Microexplants were incubated at 37uC in a humidified 5% CO2
atmosphere for 36 h, and then fixed in 4% paraformaldehyde,
processed for Ccnd1 and Pax6 ICC as described before and
counterstained with DAPI.
Migration assays
To measure the outward migration of cells from the core of the
CbA microexplants, we employed a method that was originally
described by Chou et al. (2000) [43]. Briefly, the border of the
microexplant was outlined and the average distance migrated by
Pax62/Ccnd1+ (RG/BG), Pax6+/Ccnd1+ (GCP) and Pax6+/
Ccnd12 (GC) cells (nuclei) from the border on one side of the
microexplant was measured using the Neurolucida 6 and
Neurolucida Explorer software (MBF Bioscience). The distribution
of migrating cells was categorized in 50-mm bins (distance
migrated from the border of the microexplant) using the following
procedure: a computer-generated 50650 mm grid was superim-
posed on the image on the side of the microexplant where cells had
migrated out. The number of Pax62/Ccnd1+ (RG/BG), Pax6+/
Ccnd1+ (GCP) and Pax6+/Ccnd12 (GC) cells (nuclei) within the
0–50, 50–100, 100–150, 150–200, 200–250, 250–300, 300–350
and 350–400 mm bins was counted, and the correct assignment of
the cells to each of these bins was inspected using the Neurolucida
Explorer software. A minimum of six microexplants were analyzed
for each condition, and data are derived from three independent
experiments.
Statistical analyses
All values given are mean 6 s.e.m., unless otherwise indicated.
Statistical analysis was performed with the SPSS v.10.0 (SPSS Inc.,
Chicago/USA) and GraphPad Prism 6 (GraphPad Inc./USA)
software for the behavioral data, and R software [44] for the cell
counting and cell migration data. Modified hole board, rotating
rod, cell counts and average migrated distance data were analyzed
by one-way or two-way ANOVA, and P,0.05 was considered as
significant. Students t-tests were used for post-hoc comparisons
when appropriate. Mann-Whitney U-tests were used for analysis
of rearing behavior data. In case of a non-significant interaction,
P-values were taken for genotype or treatment factor. For the cell
migration data, the proportion of Pax62/Ccnd1+ RG/BG
precursors/cells among all Ccnd1+ and Pax6+ cells was analyzed
with a logistic model for the influence of treatments, considering
the grouping of the data according to different experiments
(generalized linear mixed-effects model); the R package lme4 [45]
was used for these calculations. Confidence intervals for the
proportions were calculated with a random intercept-only model.
Results
Fgfr2 deficiency leads to locomotor deficits and an
aberrant cerebellar organization in adult mice
To establish the function of FGFR2 in developing neural
progenitors, we generated Nestin-Cre;Fgfr2lox/lox conditional knock-
out (henceforth designated as Fgfr2 cKO) mice, in which deletion
of exon 5 leads to a premature stop codon in exon 6 and
truncation of the FGFR2 protein at the extracellular Ig-like II
domain [27]. Fgfr2 exon 5-specific mRNA was only detected in the
choroid plexus (ChPl) but not in the cerebellum of adult (.8 weeks
old) Fgfr2 cKO mice (Figure 1A–D), and full-length FGFR2
protein was not detectable in the brains of these mice using an
antibody raised against the C-terminus of FGFR2 (Figure 1E).
Adult Fgfr2 cKO mice were viable and fertile; to assess their
locomotor abilities, we tested these mice on the modified hole
board (mHB) [30] and rotating rod (Rotarod). In the mHB test,
Fgfr2 cKO males showed a significantly decreased maximum
velocity and reduced total distance travelled (Figure 1F,G; Table
S1 in File S1), indicating an altered horizontal locomotion. The
mutant males also showed a significantly increased latency to the
first rearing and reduced rearing frequency on board in the middle
of the arena (Figure 1H,I; Table S1 in File S1), indicating an
altered vertical locomotion when this was not supported by the
arena wall. However, the Rotarod performance (latency to fall) of
the Fgfr2 cKO males was not significantly different from control
males (Figure 1J; Table S1 in File S1), although we noted some
variation in the latencies to fall from the Rotarod among the Fgfr2
cKO males (Figure S1 in File S1). Because of these results, we
focused our further analyses on the cerebellum of the Fgfr2 cKO
mice, although we cannot exclude that the loss of FGFR2 in other
brain regions of these mice also contributed to the observed
locomotor phenotype. Nevertheless, we did not observe any
FGFR2 in Bergmann Glia Development
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obvious alterations in the ventral mid-/hindbrain region (MHR) of
the Fgfr2 cKO mice, and dopaminergic, noradrenergic, seroto-
nergic and cholinergic neurons located in this region appeared
unaffected by the ablation of Fgfr2 in their progenitors (Figure S2
in File S1).
A detailed histological analysis of 25 adult Fgfr2 cKO cerebella
revealed that the cellular architecture of the cerebellum, partic-
ularly in the anterior lobules (lobuli II and III), was severely
disrupted in 15 (60%) mutants (Figure 2C,F,I) and was less
severely affected in 8 (32%) of the mutant mice (Figure 2B,E,H). In
the less severely affected mutant cerebella, Calbindin-expressing
(Calb1+) PCs were misaligned in the presumptive PCL and some
PCs were located within the GL, whereas Calretinin-expressing
(Calb2+) GCs intermingled with the Calb1+ PCs and occupied the
gaps devoid of PCs in the PCL (Figure 2E). By contrast, the PCL
and GL were completely disrupted in the severely affected Fgfr2
cKO cerebella, and clusters of Calb1+ PCs were surrounded by
Calb2+ GCs in these mice (Figure 2F). Because of these strong
morphological and cellular alterations in the severely affected Fgfr2
cKO cerebella, we subsequently analyzed only the less severely
affected specimens. In these mutant mice, the numbers of S100b+
BG cells appeared to be reduced in the anterior lobuli, several
S100b+ BG cell bodies were ectopically located in the ML, and the
Gfap+ radial fibers of the BG cells did not reach the pial surface of
the adult Fgfr2 cKO cerebellum (Figure 2J–M). We thus concluded
that the inactivation of Fgfr2 in neural progenitors of the
developing mouse cerebellum leads to locomotor deficits and the
disruption of the normal cellular organization and layering of the
adult cerebellum at a variable penetrance. Because a similar albeit
stronger postnatal cerebellar phenotype has been reported by Lin
et al. (2009) [20] in Fgfr1/Fgfr2 double mutant mice generated with
the same conditional mutagenesis approach, we focused our
subsequent analyses on the relative contribution of FGFR2
signaling to the developmental defects underlying these pheno-
types.
Localized expression of Fgfr2 in the developing mouse
CbA
Using a sensitive radioactive ISH method, we first assessed the
wild-type (CD-1) expression pattern of Fgfr2 in relation to Fgfr1
and Fgfr3, two other FGFRs expressed during prenatal develop-
ment (E14.5–18.5) in the murine MHR (Figure 3A–F; [19]). Fgfr2
is transcribed strongly in the ChPl and weakly in the VZ of the
dorsal midbrain (tectum) and in the overlying mesenchyme, but
not within the CbA of the E14.5 mouse embryo (Figure 3A,B;
Figure S3 in File S1). At E16.5, Fgfr2 is expressed in single cells
that appear to delaminate from the cerebellar VZ and to migrate
towards the cerebellar cortex, because several Fgfr2-expressing
cells have already accumulated in the prospective PCL
(Figure 3C,D,H). At this stage, Fgfr2 is also expressed strongly in
the ChPl and in the VZ of the dorsal midbrain (comprising the
superior and inferior colliculi), and weakly in the overlying
Figure 1. Fgfr2 deficiency leads to locomotor deficits in adult mice. (A–D) Cresyl-violet stained brightfield (A,C) and darkfield (B,D) views of
sagittal sections from adult Fgfr2lox/lox (control, A,B) and Nestin-Cre;Fgfr2lox/lox (Fgfr2 cKO, C,D) cerebella, hybridized with a radioactive Fgfr2 exon 5
riboprobe. (E) Western blotting detected the full-length FGFR2 protein (approx. 100 kD) in brain lysates of adult Fgfr2lox/lox (c, control) and Nestin-
Cre;Fgfr2+/lox (het, heterozygote) but not Nestin-Cre;Fgfr2lox/lox (hom, homozygote) mice. Hprt is the loading control. (F–J) Behavioral tests revealed an
altered horizontal locomotion (maximum velocity (F) and total distance travelled (G)) and unsupported vertical locomotion (latency to first rearing (H)
and number of rearings (I) on the board) of male Fgfr2 cKO (blue squares; n = 12 males) compared with control (red circles; n = 15 males) mice in the
modified hole board paradigm, but no significant differences between both genotypes in the accelerating Rotarod performance (measured by mean
latency to fall, J). Values are given in Table S1. I-X, lobuli of the adult cerebellum; ChPl, choroid plexus. Scale bar (C): 500 mm.
doi:10.1371/journal.pone.0101124.g001
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mesenchyme of the MHR (Figure S3 in File S1). At E18.5,
strongest expression of Fgfr2 is still detected in single cells located
within the CbA that appear to migrate towards the cerebellar
cortex and to assemble within the forming PCL (Figure 3E,F,I,J).
Fgfr2-expressing cells are not detected in the EGL, and only few
Fgfr2+ cells are located between the prospective PCL and EGL (the
prospective ML) at this stage (Figure 3I,J). Because we detected the
majority of the Fgfr2-expressing cells in the anterior CbA at E16.5
and E18.5, whereas relatively fewer Fgfr2+ cells were detected in
the posterior CbA (Figure 3C–I), the expression of Fgfr2 within the
developing CbA has the appearance of a ‘‘graded’’ anteriorhigh–
posteriorlow pattern at these stages (Figure 3D,F). At E18.5,
transcription of Fgfr2 is still strong in the ChPl but weaker in the
overlying mesenchyme (Figure S3 in File S1). Throughout all
analyzed stages, Fgfr2 is not detected in the cerebellar VZ or EGL
(Figure 3A–J; Figure S3 in File S1). Notably, visualization at high
magnification showed that the Fgfr2 ISH signal appeared to co-
localize preferentially with intensely Nissl-stained cells at E16.5
and E18.5 (Figure 3G-J), suggesting that this receptor is expressed
mainly in glial cells (RG and/or BG precursors and cells) of the
CbA at these prenatal stages. In contrast to Fgfr2, Fgfr1 is
transcribed strongly in the VZ of the CbA from E14.5 to E18.5
(Figure 3B,D,F; Figure S3 in File S1; [19]). From E16.5 on, Fgfr1 is
also expressed in single cells that appear to migrate within the CbA
and in cells that have accumulated in the emerging PCL
(Figure 3D; Figure S3 in File S1; [19]). Fgfr1 expression becomes
most prominent within the PCL at E18.5, although it is still
expressed in single cells within the CbA that appear to migrate
towards the PCL (Figure 3F; [19]). Fgfr1 is also transcribed in the
VZ of the ventral and dorsal midbrain and rostral hindbrain
throughout these stages (Figure S3 in File S1). Fgfr3 expression is
not detected in the CbA from E14.5 to E18.5 (Figure 3B,D,F), but
Fgfr3 is transcribed strongly in the VZ and in scattered cells of the
rostral hindbrain, sparing the isthmic region, at these stages
(Figure S3 in File S1). We thus concluded that Fgfr2 starts to be
transcribed after E14.5 in the developing CbA, and that Fgfr2 is
expressed in single cells located mostly within the anterior CbA.
These Fgfr2-expressing cells appear to delaminate from the
cerebellar VZ and to migrate in direction of the emerging PCL,
where they assemble toward the end of the prenatal period.
Moreover and based on their Nissl staining, these cells appear to
have a glial identity. The partial overlap of Fgfr2 and Fgfr1
expression in the developing CbA at E16.5–18.5 (Figure 3D,F)
suggests some functional redundancy between these two FGFRs in
cerebellar development. However and in contrast to Fgfr2, Fgfr1 is
prominently expressed in the cerebellar VZ, suggesting that Fgfr1
might additionally be involved in the generation and/or mainte-
nance of VZ progenitor cells.
Figure 2. Aberrant cellular layering and organization of the adult Fgfr2 cKO cerebellum. (A–F) Representative confocal images of sagittal
sections from adult control (A; n = 2 mice) and Fgfr2 cKO (B,C; n = 5 mice) cerebella, double-immunostained for calbindin (Calb1, green) and calretinin
(Calb2, red), and counterstained with DAPI (blue). (D–F) are higher magnifications of the boxed areas in (A–C). White arrowheads in (E) point at
ectopically located Calb1+ PCs within the GL, and white arrows in (E) denote the PC ‘‘gaps’’ within the PCL occupied by Calb2+ GCs. White arrowheads
in (F) point at Calb1+ PC clusters surrounded by Calb2+ GCs. (G–I) Representative sagittal sections from adult control (G; n = 15 mice) and Fgfr2 cKO
(H,I; n = 20 mice) cerebella hybridized with a riboprobe for Gad2, which is expressed in PCs and GABAergic interneurons within the ML. Black
arrowheads in (H,I) point at the disorganized Gad2+ PCL in the anterior lobules (II and III) of the mutant cerebella. The cerebella shown in (B,E,H)
display a milder phenotype, which was detected in 8/25 (32%) of the Fgfr2 cKO mice. The cerebella shown in (C,F,I) display a more severe phenotype,
detected in 15/25 (60%) of the mutants. (J–M) Representative immunostainings for S100b (J,K) and Gfap (L,M) on sagittal sections from adult control
(J,L) and less severely affected Fgfr2 cKO (K,M) cerebella. Note the reduced numbers of S100b+ BG cells within the PCL and ectopic positioning of
S100b+ BG cells within the ML in the mutant cerebellum. Gfap+ BG fibers did not reach the pial surface of the mutant cerebellum. GL, granular layer;
ML, molecular layer; PCL, Purkinje cell layer; II and III, lobuli of the adult cerebellum. Scale bars: 500 mm (A,G), 50 mm (D), 100 mm (J,L).
doi:10.1371/journal.pone.0101124.g002
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Next, we analyzed the expression of Fgfr2 and of the other three
mouse Fgfr genes in the CbA of the Fgfr2 cKO embryos at E18.5
(Figure 3K–R). Transcription of Fgfr2 was completely lost
(Figure 3K,L) and Fgfr1 appeared to be reduced in the PCL but
not in the VZ of the mutant CbA (Figure 3M,N), whereas the
expression of Fgfr3 and Fgfr4 was not altered in the mutants
(Figure 3O–R), indicating that the inactivation of Fgfr2 might have
affected the expression of Fgfr1 but not of the other two Fgfrs in the
developing mouse cerebellum.
Reduced numbers and mispositioning of BG cells in the
EGL are the primary cerebellar defects in the Fgfr2 cKO
embryos
The previous results indicated a strong correlation between the
higher expression of Fgfr2 in the developing anterior CbA,
particularly in what appeared to be migrating glial cells
(Figure 3), and the prominent anterior PC, GC and BG layering
defects in the adult Fgfr2 cKO cerebella (Figure 2). These defects
are expected to arise between E14.5 and E16.5, because Fgfr2 is
not expressed in the CbA before E14.5 (our data and [19]).
Indeed, initial defects were apparent at E16.5 in the CbA of the
Figure 3. Expression of Fgfr2 within the developing mouse CbA. (A–F) Representative brightfield views of Cresyl-violet-stained midsagittal
sections (A,C,E) and darkfield views of pseudo-colored overlays from consecutive midsagittal sections hybridized with radioactive Fgfr1 (red), Fgfr2
(green) and Fgfr3 (blue) riboprobes (overlapping expression domains appear in yellow) (B,D,F) through the CbA of wild-type (CD-1) mouse embryos
at E14.5 (A,B; n = 5 embryos), E16.5 (C,D; n = 5 embryos) and E18.5 (E,F; n = 6 embryos). (G) Schematic overview of a midsagittal section through the
embryonic MHR. The red box delimits the CbA, shown at higher magnification in (H,I). (H–J) Cresyl-violet-stained and pseudo-colored midsagittal
sections through the CbA of wild-type (CD-1) mouse embryos at E16.5 (H, same section as in C) and E18.5 (I,J, same section as in E) hybridized with a
radioactive Fgfr2 riboprobe (red). (J) is a higher magnification of the boxed area in (I). Note that the majority of the Fgfr2-expressing cells are intensely
Nissl-stained (glial) cells (black arrowheads in J) located mostly in the anterior CbA at these stages (depicted by the black triangle and highRlow
gradient below (D,F)). (K–R) Representative midsagittal darkfield (K,L,O-R) and brightfield (M,N) views of the CbA in E18.5 control (K,M,O,Q; n = 5
embryos) and Fgfr2 cKO (L,N,P,R; n = 5 embryos) embryos hybridized with radioactive Fgfr2 exon 5 (K,L), Fgfr1 (M,N), Fgfr3 (O,P) and Fgfr4 (Q,R)
riboprobes. CbA, cerebellar anlage; ChPl, choroid plexus; EGL, external granular layer; IC, inferior colliculus; PCL, Purkinje cell layer; rH, rostral
hindbrain; rl, rhombic lip; SC, superior colliculus; Tg, tegmentum; VZ, cerebellar ventricular zone. Scale bars: 500 mm (F), 50 mm (J), 100 mm (Q).
doi:10.1371/journal.pone.0101124.g003
FGFR2 in Bergmann Glia Development
PLOS ONE | www.plosone.org 6 July 2014 | Volume 9 | Issue 7 | e101124
mutant embryos, and detected in 15 out of 28 (,54%) Fgfr2 cKO
embryos. Double immunostaining for the neural progenitor
marker Sox2, which is also expressed in RG/BG cells [46–48],
and the RG/BG marker Blbp (also known as brain fatty acid
binding protein 7, Fabp7) [7,47,49,50], revealed a strong
reduction of Sox2- and Blbp-expressing cells in the CbA of the
Fgfr2 cKO embryos at E16.5 and E18.5 (Figure 4A,D,G,I). A
reduction of Sox2+ and Blbp+ neural progenitors and RG/BG
precursors was also apparent in the anterior part of the cerebellar
VZ of the mutant embryos at E16.5 (Figure 4A,D) whereas at
E18.5, Sox2+ and Blbp2 neural progenitor cells appeared to
accumulate in the cerebellar VZ of the mutant embryos
(Figure 4G,I). Furthermore, only few Blbp+ RG/BG processes
reached the pial surface of the mutant CbA, and these fibers were
frequently arranged in a parallel (tangential) rather than perpen-
dicular (radial) manner relative to this surface in the Fgfr2 cKO
embryos (Figure 4B,C,E,F,H,J). Notably, we also detected an
increased number of ectopically positioned Sox2+/Blbp+ BG cells
within the EGL of the mutant embryos compared with the control
embryos at both stages (Figure 4B,C,E,F,H,J). Because the strong
reduction of Sox2+ and Blbp+ cells already indicated a defective
generation and/or differentiation of BG cells in the Fgfr2 cKO
embryos, we also determined the expression of Tenascin C (Tnc),
an extracellular matrix glycoprotein whose mRNA is localized to
the somata of RG precursors and BG cells and considered as one
of the earliest marker for nascent BG [36,47]. Tnc is transcribed in
cells located in the cerebellar VZ, in single cells within the CbA,
and in cells that begin to align within the PCL along the entire
anterior-posterior extent of the CbA in E16.5–E18.5 control mice
(Figure 5A,C,E,I). Only very few Tnc-expressing cells were
detected within the EGL of control embryos at E16.5 and later
stages (Figure 5A,C,E,I,N). In the CbA of the Fgfr2 cKO embryos,
by contrast, the numbers of Tnc+ cells were strongly reduced
already at E16.5 (Figure 5B,D,F,J,M). Moreover, many Tnc-
expressing cells were ectopically positioned within the EGL of the
mutant CbA (Figure 5B,D,F,J,N). Intensely Nissl-stained (glial)
cells located within the forming PCL or migrating towards this
layer showed an ISH signal for Fgfr2 and Tnc in control embryos
(Figure 5E,G,K,L). The ISH signal for Fgfr2 was completely lost in
the mutant CbA, and fewer intensely Nissl-stained and Tnc-
expressing cells were detected within the forming PCL or en route
towards this layer in the Fgfr2 cKO embryos (Figure 5F,H). These
results suggested that it is in fact the cell-autonomous loss of
FGFR2 function in glial cells (RG and BG) that causes the
defective generation of BG cells and their abnormal positioning
within the EGL in the mutant embryos.
We next assessed whether the PCs (expressing Calb1, [51]) and
GCPs (expressing Pax6 and Cyclin D1 (Ccnd1), [52–54]) had
acquired their molecular identity and correct position within the
developing CbA of the Fgfr2 cKO embryos. At E18.5, Calb1+ PCs
had not formed a multilayer underlying the most anterior (rostral)
part of the Pax6+ EGL (Figure 6A–D), indicating a disrupted
formation of the anterior PCL in the mutant embryos. Further-
more, Pax6+ GCPs were not aligned in a clearly delimited anterior
EGL as in control embryos, and the mutant anterior EGL
appeared to be slightly distorted with single Pax6+ GCPs
protruding into the CbA (Figure 6A–D). In line with these
observations, the arrangement of cycling Ccnd1+ GCPs within the
outer EGL also appeared to be distorted in the anterior CbA of the
Fgfr2 cKO embryos (Figure 6E–J). Moreover, a reduced number
of RG/BG precursors/cells expressing Ccnd1 [54,55] was
apparent in the mutant CbA at this stage, and some of these
cells were ectopically located within the cerebellar VZ of the Fgfr2
cKO embryos (Figure 6E–J). The glial high affinity glutamate
transporter Glast (also known as Slc1a3 or Eaat1) is expressed in
RG and BG cells and fibers [56]. Despite an apparently normal
formation of the Glast+ RG fiber scaffold in the CbA of the mutant
embryos, and concordantly with the decreased Ccnd1+ cells in this
region, the Glast+ signal appeared to be reduced in the mutant
PCL (Figure 6K,L). Because the PC and GCP defects appeared
only at around E17.5 (Figure S4 in File S1; see also Figure 7 for
Math1 (Atoh1) detection in the E16.5 EGL), i.e. at least one day
after the BG defects were detected in the Fgfr2 cKO embryos, we
concluded that the reduced numbers of RG/BG precursors/cells
and the ectopic positioning of BG cells in the mutant EGL are the
primary cerebellar defects in the Fgfr2 cKO embryos.
Reduced cell survival in the anterior CbA of the Fgfr2 cKO
embryos
The reduced numbers of Sox2+/Blbp+ and Tnc+ RG/BG
precursors/cells, and the disrupted formation of the presumptive
anterior PCL, suggested that the proliferation of the BG and/or
PC progenitors located in the VZ of the mutant CbA and/or their
survival might also be affected in the absence of Fgfr2. The latter
possibility was more likely in the Fgfr2 cKO embryos because Fgfr2
is not expressed in the cerebellar VZ and Fgfr1 expression was not
altered in this region of the mutant CbA (Figure 3). Indeed, the
numbers of mitotic (pH3+) cells in the VZ of the CbA were not
significantly different between control and Fgfr2 cKO embryos at
E16.5 (Figure 7A,B,G), suggesting that the proliferation of BG
and/or PC progenitors was not affected in the mutant embryos at
this stage. The numbers of apoptotic (cCasp3+) cells, by contrast,
were significantly increased by ,1.7-fold in the anterior CbA of
the Fgfr2 cKO embryos at E16.5 (Figure 7C,D,H), indicating that
cell survival within the CbA was compromised in the mutant
embryos. The increased apoptotic cell death in the anterior CbA
of the Fgfr2 cKO embryos coincided with a slight but not
significant decrease of the total area of the mutant CbA by,9% at
E16.5 (control: 10.02610560.646105 mm2; Fgfr2 cKO:
9.14610560.736105 mm2; P=0.40 Student’s t-test) and ,10%
at E18.5 (control: 3.01610660.266106 mm2; Fgfr2 cKO:
2.73610660.156106 mm2; P=0.40 Student’s t-test). Because the
increased (,1.7-fold) number of apoptotic cells corresponded with
the decreased (,1.5-fold) number of Tnc+ cells, we concluded that
the reduced number of RG/BG precursors/cells in the mutant
CbA might also be due to a reduced survival of these cells in the
absence of FGFR2 signaling.
The generation of the EGL and GCPs was not affected in the
Fgfr2 cKO embryos, as determined by the normal expression of
Atoh1 (Math1), a transcription factor required for EGL and GCP
development [57], in the developing mutant CbA at E16.5 and
E18.5 (Figure 7E,F and data not shown). We also determined
whether the proliferation and cell-cycle exit of GCPs in the
anterior (rostral) EGL might have been affected in the Fgfr2 cKO
embryos. The density of Pax6+ GCPs and proliferating (EdU+)
cells in the anterior EGL (Figure 7I–K), as well as the fraction of
proliferating Pax6+ GCPs that had incorporated EdU after a single
pulse given 24 h before (EdU+ and Pax6+ cells per total Pax6+
cells: control, 47.562.7%; Fgfr2 cKO, 48.960.1%; P=0.65 in the
Student’s t-test), were not significantly different between control
and mutant embryos at E18.5, indicating that the numbers and
the proliferation/cell-cycle exit of Pax6+ GCPs in the anterior
EGL were not affected by the loss of Fgfr2 expression in the CbA.
Together, the previous results suggested that FGFR2-mediated
signaling is also required for the proper survival of RG/BG
precursors/cells and PCs within the CbA.
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FGF target gene activation is almost completely
abolished in the CbA of the Fgfr2 cKO embryos
To confirm that FGF signaling was in fact reduced or abolished
in those regions of the mutant CbA where Fgfr2 is highly expressed
(anterior CbA including the anterior PCL but excluding the VZ,
see Figure 3), we determined the transcription of a known FGF
target gene, Etv5 (Erm, [19,58]) in the developing CbA of control
and Fgfr2 cKO embryos. At E16.5 and E18.5, Etv5 is strongly
expressed in the cerebellar VZ, in scattered cells within the CbA,
in the emerging PCL and in the posterior EGL of control embryos
(Figure 8A,I; [19]). By contrast, transcription of Etv5 was strongly
reduced in almost the entire CbA (including the VZ and the PCL
primordium but excluding the posterior EGL) of the mutant
embryos at E16.5, and was almost completely abolished at E18.5
(Figure 8B,J). Notably, Etv5 was ectopically expressed in the
anterior EGL of the Fgfr2 cKO embryos at both stages
Figure 4. Strong reduction and ectopic positioning of Sox2+/Blbp+ BG precursors and cells in the Fgfr2 cKO CbA. (A–J) Representative
confocal overviews (A,D,G,I) and close-up views (B,C,E,F,H,J) of the CbA on sagittal sections from control (A,B,C,G,H) and Fgfr2 cKO (D,E,F,I,J) embryos
at E16.5 (A–F; n = 4 embryos/genotype) and E18.5 (G–J; n = 3 embryos/genotype), immunostained for Sox2 (green) and Blbp (Brain lipid binding
protein, red). A marked reduction of Sox2+/Blbp+ BG precursors/cells was observed in the Fgfr2 cKO (D,I) compared to control (A,G) embryos at both
stages. A reduction of Sox2+ and Blbp+ neural progenitors and RG/BG precursors was also apparent in the anterior (left) part of the cerebellar VZ of
the mutant embryos at E16.5 (A,D), whereas at E18.5, Sox2+ and Blbp2 neural progenitor cells appeared to accumulate in the cerebellar VZ of the
Fgfr2 cKO embryos (G,I). Close-up views (B,C,E,F,H,J) of the boxed areas in (A,D,G,I) revealed an increased number of ectopically positioned Sox2+/
Blbp+ BG cells (white arrowheads) within the EGL of the Fgfr2 cKO embryos at E16.5 and E18.5. Only few Blbp+ BG fibers reached the pial surface
(dashed line in C,F) of the mutant CbA, and these fibers were frequently arranged in a parallel (tangential) rather than perpendicular (radial) manner
relative to this surface (white arrows in E,J). EGL, external granular layer; PCL, Purkinje cell layer; VZ, cerebellar ventricular zone. Scale bars: 500 mm (A),
100 mm (B,C).
doi:10.1371/journal.pone.0101124.g004
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(Figure 8C,D,K,L). The ectopic Etv5-expressing cells clearly
outnumbered the ectopically positioned Tnc+ cells in the anterior
EGL of the mutant embryos (Figure 8C–F,K–N). Moreover, the
ectopic Etv5+ cells were largely confined to the outer EGL at E18.5
(Figure 8L,P), whereas the ectopic Tnc+ cells were predominantly
located in the inner EGL at this stage (Figure 8N,P), indicating
that FGF signaling was ectopically activated in cells other than the
ectopically positioned Tnc+ BG cells in this region of the mutant
CbA. These results showed that FGF signaling and target gene
activation were in fact strongly reduced or even abolished within
the CbA, in the cerebellar VZ and in the forming PCL of the Fgfr2
cKO embryos, thus including regions where Fgfr2 is not or only
weakly expressed (the VZ and posterior CbA/PCL, see Figure 3).
As this correlated with an apparent reduction of Fgfr1 expression
in the mutant CbA (including the emerging PCL, Figure 3), we
concluded that the lack of FGFR2-mediated signaling makes a
major contribution to the BG and PC defects in the Fgfr2 cKO
embryos, but might additionally be reinforced by a reduction of
FGFR1-mediated signaling in these embryos.
We next determined whether the relatively subtle PCL and
EGL defects in the Fgfr2 cKO embryos might be due to an altered
expression of Shh in PCs or a defective SHH signal transduction in
GCPs. The transcription of Shh and the SHH target gene Ptch1
was not changed in the developing CbA of the mutant embryos
compared with control embryos, except for a notable lack of the
Shh+ PCL underlying the most anterior (rostral) EGL in the Fgfr2
cKO embryos at E18.5 (Figure S5 in File S1). The latter
observation is most likely due to the lack of Calb1+ PCs in the most
anterior PCL of the mutant embryos (see Figure 6). Together,
these results suggested that the expression of Shh in migrating and
stationary PCs and its target gene Ptch1 in GCPs is not altered by
the reduced or even abolished FGF signaling in the mutant CbA,
Figure 5. Reduced numbers and mispositioning of Tnc+ BG cells in the EGL of the Fgfr2 cKO CbA. (A–J) Representative sagittal brightfield
views of E16.5 (A–D, n = 4 embryos/genotype), E17.5 (E–H, n = 1 embryo/genotype) and E18.5 (I,J, n = 3 embryos/genotype) control (A,C,E,G,I) and
Fgfr2 cKO (B,D,F,H,J) cerebella hybridized with radioactive Tnc (A–F,I,J) and Fgfr2 (G,H) riboprobes. (C,D) are higher magnifications of the boxed areas
in (A,B). (E–H) are higher magnifications of the anterior CbA in adjacent sections from control or mutant embryos. Red arrowheads in (D,F) point at
ectopically positioned Tnc+ BG cells in the mutant EGL. Note the complete absence of the Fgfr2 ISH signal correlating with less Tnc+ and intensely
Nissl-stained cells in the CbA of the Fgfr2 cKO embryo shown in (F,H), although some Fgfr2+ cells are detected in the (non-neural) mesenchyme
overlying the mutant EGL. Red dotted line in (A,I) delimits the anterior area used for quantification. (K,L) High magnification views of the EGL and PCL
on adjacent sections from an E18.5 control (wild-type) embryo, hybridized with a radioactive riboprobe for Fgfr2 (red in K) or Tnc (black in L). Black
arrowheads point at intensely Nissl-stained cells showing an ISH signal for Fgfr2 (K) or Tnc (L). Empty arrowheads point at larger, weakly Nissl-stained
cells devoid of Fgfr2 (K) or Tnc (L) ISH signals. (M,N) Quantification of Tnc+ cells in the anterior CbA (M) and EGL (N) of control (grey bars) and mutant
(white bars) embryos at E16.5 and E18.5 (Tnc+ cells/mm2 (M): E16.5: control, 6.496102462.561025 (n = 4 embryos); Fgfr2 cKO, 4.436102462.461025
(n = 4 embryos); E18.5: control, 9.416102465.961025 (n = 3 embryos); Fgfr2 cKO, 6.256102465.661025 (n = 3 embryos); Tnc+ cells in anterior EGL (N):
E16.5: control, 3.0060.41 (n = 4 embryos); Fgfr2 cKO, 17.0061.29 (n = 4 embryos); E18.5: control, 5.6760.88 (n = 3 embryos); Fgfr2 cKO, 13.3362.33
(n = 3 embryos); Student’s t-test). EGL, external granular layer; PCL, Purkinje cell layer; VZ, cerebellar ventricular zone. Scale bars: 100 mm (B); 50 mm
(D,H); 30 mm (L).
doi:10.1371/journal.pone.0101124.g005
FGFR2 in Bergmann Glia Development
PLOS ONE | www.plosone.org 9 July 2014 | Volume 9 | Issue 7 | e101124
and is therefore unlikely to contribute to the PCL and EGL defects
in the Fgfr2 cKO embryos.
FGF9/FGFR signaling inhibits the migration of RG/BG
precursors/cells in cerebellar microexplants in vitro
In addition to the loss of RG/BG precursors/cells, the radial
migration of Sox2+/Blbp+ and Tnc+ BG cells within the CbA did
not stop at the level of the PCL, leading to the ectopic positioning
of BG cells within the prenatal EGL or adult ML, respectively, of
the Fgfr2 cKO mice (Figures 2, 4, 5). This suggested that FGFs
secreted from the EGL and/or PCL inhibit the further migration
of RG/BG precursors/cells, thereby controlling their correct
alignment within the developing PCL. To test this hypothesis, we
prepared CbA microexplant cultures from E16.5 wild-type (CD-1)
embryos and treated them for 36 h with control medium or
medium containing recombinant human FGF9 or SU5402
(Figure 9A). FGF9 is an FGF expressed by GCPs and PCs, and
required for the proper differentiation and alignment of BG cells
in the mouse cerebellum [19,20], whereas SU5402 is a known
inhibitor of FGFR signaling [59]. After immunocytochemical
staining for Pax6, a marker for GCPs and migrating GCs as well as
other cells located within the CbA (Figures 6A, 9A, S4 in File S1;
[52]), and Ccnd1 (Cyclin D1), which is expressed in proliferating
GCPs from the outer EGL and in RG/BG precursors/cells within
the CbA and forming PCL but not in VZ progenitors (Figures 6E,
9A, S4 in File S1; [53–55]), we determined the distance migrated
by each cycling Pax6+/Ccnd1+ GCP and Pax62/Ccnd1+ RG/BG
precursor/cell or postmitotic Pax6+/Ccnd12 GC from the border
of the microexplant (Figure 9A). The average distance migrated by
Pax6+/Ccnd1+ GCPs did not show any notable differences
between control-, FGF9- and SU5402-treated cultures
(Figure 9B–E), whereas the average distance migrated by
Pax62/Ccnd1+ RG/BG precursors/cells was reduced after
FGF9 treatment and slightly increased after SU5402 treatment
relative to the control-treated cultures, although it did not reach
statistical significance because of the high variance of migrated
distances within and between experiments (Figure 9B–E). Because
this already hinted at a migration-inhibiting effect of FGF9 and
migration-promoting effect of the FGFR inhibitor SU5402 on
RG/BG precursors/cells but not on GCPs, we analyzed the
migratory behavior of RG/BG precursors/cells under these
conditions in more detail. FGF9 treatment reduced significantly
the proportion of Pax62/Ccnd1+ RG/BG precursors/cells among
the total number of Ccnd1 and Pax6 single- and double-positive
cells (including Pax62/Ccnd1+ RG/BG, Pax6+/Ccnd1+ GCPs
and Pax6+/Ccnd12 GCs, Figures 6A, 6E, 9A) that had migrated
from the core of the microexplant (regardless of distance) relative
to the control- and SU5402-treated explants (Figure 9F), indicat-
ing that FGF9 in fact inhibited the outward migration of RG/BG
precursors/cells in these cultures. Next, we assessed the proportion
of Pax62/Ccnd1+ RG/BG precursors/cells among all Ccnd1 and
Pax6 single- and double-positive cells in 50-mm bins from the
border of the microexplants (Figure 9A,G; Table S2 in File S1).
We noted that under control conditions, the average proportion of
RG/BG precursors/cells in each bin corresponded well with a
normal distribution according to the distance migrated, with fewer
or no cells in the more proximal and distal bins, respectively,
relative to the border of the microexplants (Figure 9B,G). After
FGF9 treatment, however, the average proportion of RG/BG
precursors/cells in each bin was strongly decreased and these cells
were only detected up to a distance of 200–250 mm from the
border of the microexplants (Figure 9C,G), indicating that the
distance migrated by the RG/BG precursors/cells was also
reduced in the FGF9-treated cultures. Treatment of the micro-
explants with SU5402, by contrast, strongly increased the average
proportion of RG/BG precursors/cells particularly in the more
distal bins and these cells were detected up to a distance of 350–
400 mm from the border of the microexplants (Figure 9D,G),
indicating that the inhibition of FGFR signaling augmented the
distance migrated by the RG/BG precursors/cells in vitro in a
similar manner to what was observed in the Fgfr2 cKO embryos in
vivo (Figures 4,5). Together, these data showed that FGF9 inhibits
the outward migration of RG/BG precursors/cells whereas
Figure 6. Disruption of the anterior PCL but apparently normal RG scaffold in the Fgfr2 cKO CbA. (A–N) Representative confocal
overviews (A,B,E,F) and close-up views (C,D,G–N) of the anterior CbA on sagittal sections from control (A,C,E,G,I,K,M) and Fgfr2 cKO (B,D,F,H,J,L,N)
embryos at E18.5 (n = 5 embryos/genotype), immunostained for Pax6 (cyan/green in A–D; a marker for GCPs) and Calb1 (red in A–D; a marker for PCs),
or Ccnd1 (cyan/green in E–J; a marker for cycling GCPs and RG/BG precursors/cells) and Glast (red in E–H,K,L; a marker for RG/BG fibers), and
counterstained with DAPI (blue in A–H,M,N; a nuclear marker). (C,D) and (G,H) are close-up views of the boxed areas in (A,B) and (E,F), respectively,
(G,I,K,M) were taken from an adjacent section to the one shown in (E). (I–N) are single color channel views of (G,H), respectively. Yellow arrowheads in
(D) delimit the lacking Calb1+ anterior PCL in the mutant embryos, and in (H,J) point at ectopically located Ccnd1+ RG/BG precursors within the
mutant cerebellar VZ. White arrowheads in (H,J) delimit the distorted Ccnd1+ anterior outer EGL in the mutant embryos. EGL, external granular layer;
PCL, Purkinje cell layer; VZ, cerebellar ventricular zone. Scale bars: 100 mm (A); 30 mm (C); 50 mm (E).
doi:10.1371/journal.pone.0101124.g006
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blocking FGFR signal transduction has the opposite effect and
promotes the outward migration of these cells for longer distances
from the microexplant, and thus strongly suggested that during
cerebellar development, FGF9/FGFR2-mediated signaling in
migrating RG/BG precursors/cells inhibits their further migration
beyond their proper position within the PCL.
Discussion
We show here that the conditional inactivation of Fgfr2 in neural
progenitors results in specific cellular and layering defects in
particular in the anterior (rostral) cerebellum of adult Fgfr2 cKO
mice, where Fgfr2 is highly expressed during normal CbA
development. The developmental deficits in these mice include a
reduced generation and ectopic positioning of BG cells within the
EGL, the misalignment and lack of PCs in the most anterior PCL,
and a reduced cell survival in the developing CbA. We also show
that FGF9/FGFR2-mediated signaling inhibits the outward
migration of RG/BG precursors/cells in vitro, and might thereby
control the correct positioning of BG cells within the PCL in vivo.
Figure 7. Reduced cell survival in the CbA of the Fgfr2 cKO embryos. (A–D) Representative high magnification views of the VZ in the anterior
CbA on sagittal sections of E16.5 control (A,C; n = 4 embryos) and Fgfr2 cKO embryos (B,D; n = 4 embryos), immunostained for phosphorylated
Histone H3 (phosphoH3) (A,B) and cleaved (activated) Caspase3 (cCasp3) (C,D). Red arrowheads point at phosphoH3+ or cCasp3+ cells, respectively.
(E,F) Representative overviews of the CbA from E16.5 control (E; n = 4 embryos) and Fgfr2 cKO embryos (F; n = 4 embryos), hybridized with a
radioactive riboprobe for Atoh1 (Math1). (G,H) Quantification of phosphoH3+ (G) and cCasp3+ (H) cell densities in the anterior CbA of E16.5 control
(grey bars) and mutant (white bars) embryos (phosphoH3+ cells/mm2 (G): control, 10.46102460.1861023 (n = 4 embryos); Fgfr2 cKO,
10.76102460.1361023 (n = 4 embryos); cCasp3+ cells/mm2 (H): control, 1.266102560.1161025 (n = 4 embryos); Fgfr2 cKO, 2.176102560.1561025
(n = 4 embryos); Student’s t-test). (I,J) Representative high magnification views of the EGL in the anterior CbA on sagittal sections of E18.5 control (I,
n = 3 embryos) and Fgfr2 cKO (J, n = 2 embryos) cerebella, immunostained for Pax6 (green) and EdU (red). (K) Quantification of Pax6+ GCP and
proliferating EdU+ cell densities in the anterior EGL of E18.5 control (grey bars) and mutant (white bars) embryos (Pax6+ cells/mm2: control:
2.006102260.0561022 (n = 3 embryos); Fgfr2 cKO: 2.116102260.0261022 (n = 2 embryos); EdU+ cells/mm2: control: 0.956102260.0461022 (n = 3
embryos); Fgfr2 cKO: 1.036102260.0161022 (n = 2 embryos); Student’s t-test). EGL, external granular layer; VZ, ventricular zone. Scale bars: 50 mm
(C,I); 100 mm (F).
doi:10.1371/journal.pone.0101124.g007
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FGFR2-mediated signaling promotes the generation of
BG cells and cell survival in the developing CbA
Adult Fgfr2 cKO mice displayed similar but generally weaker
cerebellar defects than previously described in Fgfr1/Fgfr2 double
mutant (Nestin-Cre;Fgfr1flox;Fgfr2flox [20] and hGFAP-Cre;Fgfr1f/f;
Fgfr2f/f [21]) mice. Therefore, we determined the relative contribu-
tion of the lack of Fgfr2 to these phenotypes. Our results indicated
that Fgfr2 transcription in the developing CbA starts after E14.5, is
highest in cells located in its anterior (rostral) part including the
anterior PCL, and spares the cerebellar VZ. Fgfr1, by contrast, is
transcribed at high levels in a much broader area including the
posterior CbA/PCL and the entire cerebellar VZ [19]. The anterior
CbA gives rise to the anterobasal lobe around birth, which generates
the anterior lobules (lobuli I–III) of the adult cerebellum [1];
correspondingly, these lobules were the most affected in the adult
Fgfr2 cKO cerebellum. A stronger phenotype in the anterior
cerebellum was also noted in FGF signaling loss-of-function (LOF)
(hGFAP-Cre;Fgfr1f/f;Fgfr2f/f [21]) and gain-of-function (GOF)
(En1cre/+;Spry1flox/flox;Spry2flox/flox [22]) mutant mice, suggesting that
the restricted high expression of Fgfr2 in the anterior CbA imposes a
stronger need of a balanced FGF signaling for the proper
development of this region. Nevertheless, the strongly reduced or
even abolished transcription of the FGF target gene Etv5 in the
entire CbA (except the EGL) of the Fgfr2 cKO embryos, including
the cerebellar VZ and posterior CbA regions where Fgfr2 is not
expressed at detectable high levels, suggests a contribution of the
apparently decreased Fgfr1 expression to the cerebellar phenotypes
of the Fgfr2 single mutant mice (see comments below).
The most notable defect in the developing CbA of the Fgfr2
cKO embryos was a strong reduction of Sox2-, Blbp- and Tnc-
expressing BG precursors and cells that became apparent already
at E16.5, i.e. less than two days after the failed induction of Fgfr2
expression in the corresponding neural progenitors. Sox2+ neural
progenitors indeed appeared to accumulate over time in the
cerebellar VZ of the Fgfr2 cKO embryos, suggesting that these
Figure 8. FGF target gene activation is almost completely abolished in the CbA of Fgfr2 cKO embryos. (A–P) Representative sagittal
brightfield views of E16.5 (A–H; n = 5 embryos/genotype) and E18.5 (I-P; n = 4 embryos/genotype) control (A,C,E,G,I,K,M,O) and Fgfr2 cKO
(B,D,F,H,J,L,N,P) cerebella, hybridized with riboprobes for Etv5 (A–D,I–L) and Tnc (E,F,M,N). (C,D) and (K,L) are higher magnifications of the boxed areas
in (A,B) and (I,J), respectively. (G,H) and (O,P) are pseudo-colored overlays (Etv5 in red, Tnc in green, overlapping expression domains appear in yellow)
of the adjacent sections shown in (C–F) and (K–N), respectively. Red arrowheads in (D,F,L,N) point at ectopic Etv5+ (D,L) or Tnc+ (F,N) cells in the
anterior EGL of the mutant embryos. Note that at E18.5, the ectopic Etv5+ cells are predominantly located in the outer margin of the EGL, whereas the
ectopic Tnc+ cells are mostly confined to the inner EGL. EGL, external granular layer; PCL, Purkinje cell layer. Scale bars: 100 mm (B); 50 mm (H).
doi:10.1371/journal.pone.0101124.g008
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Figure 9. FGF9/FGFR signaling inhibits the migration of RG/BG precursors/cells in cerebellar microexplants in vitro. (A) Migration
assays were performed with similarly sized (black dotted bars) CbA microexplants from E16.5 wild-type (CD-1) mice, containing Pax6+/Ccnd1+ GCPs in
the outer EGL (yellow), Ccnd1+ RG/BG precursors and cells (green), Pax6+ postmitotic GCs and inner CbA cells (pink), and DAPI+ PCs (blue). ChPl,
choroid plexus; EGL, external granular layer; IC, inferior colliculus; VZ, cerebellar ventricular zone. CbA microexplants were treated with control
medium or medium containing 100 ng/ml FGF9 or 20 mM SU5402. The distance (d) migrated by each Pax62/Ccnd1+ (green), Pax6+/Ccnd1+ (yellow)
and Pax6+/Ccnd12 (pink) cell from the border of the microexplant was measured after 36 h of incubation. (B–D) Representative confocal overviews
of Ccnd1+ (green) and/or Pax6+ (red) cells (double-positive cells appear in yellow), counterstained with DAPI (blue) (overlays with single-positive cells
appear in light green and pink, respectively), that migrated from the border of the CbA microexplant (white line) in control (B), FGF9- (C) or SU5402-
(D) containing medium. Red arrowheads point at the front-most Ccnd1+/Pax62 (green) cells. (E) Quantification of the average distance migrated by
RG/BG precursors/cells (green bars) and GCPs (yellow bars) in control- (n = 8 explants), FGF9- (n = 8 explants) or SU5402- (n = 6 explants) treated
microexplant cultures (Distance (mm): RG/BG precursors/cells, control, 86.2616.8; +FGF9, 52.6620.9; +SU5402, 89.3633.2; GCPs, control, 111.7615.3;
+FGF9, 97.7616.8; +SU5402, 100.2615.6; one-way ANOVA). (F) Quantification of the proportion of Ccnd1+/Pax62 RG/BG precursors/cells among the
total number of migrating Ccnd1+ and/or Pax6+ cells in control-, FGF9- or SU5402-treated microexplant cultures (% Ccnd1+/Pax62 RG/BG precursors/
cells: control, 3.66, 95% confidence interval [2.95,4.48] (8 experiments for controls with 128–589 migrated cells, among them 2-29 RG/BG cells); +FGF9,
1.31, 95% confidence interval [0.84,1.92] (8 experiments for FGF9 with 79-501 migrated cells, among them 0–9 RG/BG cells); +SU5402, 2.89, 95%
confidence interval [1.99,4.04] (6 experiments for SU5402 with 78–371 migrated cells, among them 0–15 RG/BG cells); P-values from contrasts of a
logistic model). (G) Average proportions of Ccnd1+/Pax62 RG/BG precursors/cells among the total number of migrating Ccnd1+ and/or Pax6+ cells in
each 50-mm bin in control- (grey bars), FGF9- (red bars) or SU5402- (green bars) treated microexplant cultures were estimated with a logistic model.
Values are given in Table S2 in File S1. Scale bar (D): 100 mm.
doi:10.1371/journal.pone.0101124.g009
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cells failed to generate the proper amount of migrating Blbp+ and
Tnc+ BG precursors/cells in the absence of Fgfr2. A similar albeit
much stronger BG phenotype was recently described in condi-
tional mouse mutants for the protein tyrosine phosphatase, non-
receptor type 11 gene (Ptpn11, also known as Shp2), an intracellular
effector of the FGF/FGFR signaling pathway (En1;Ptpn11CKO
mice, [47]). The generation of BG is completely abolished in these
mice, apparently because RG fails to transform into BG in the
absence of Ptpn11, which subsequently leads to foliation defects in
the mutant cerebella [47]. Our results thus suggest that FGFR2 is
primarily involved in the transduction of FGF signals required for
the proper transformation and/or differentiation of RG precursors
into BG cells.
We also observed a slightly increased number of apoptotic cells
within the CbA of the Fgfr2 cKO embryos. The reduced cell
survival most likely includes migrating and stationary PC and RG/
BG precursors/cells that are born at earlier developmental stages
in the cerebellar VZ, and might contribute to the reduced
numbers of Sox2+/Blbp+/Tnc+/S100b+ RG/BG precursors/cells
and to the lack of Calb1+ PCs in the anterior PCL of the
embryonic and adult Fgfr2 cKO cerebellum. BG cells are also
decreased in the hGFAP-Cre;Fgfr1f/f;Fgfr2f/f cerebellum, although
apoptotic cell numbers do not appear to be changed in these mice
[21]. In contrast to cell survival, the proliferation of cerebellar VZ
progenitors was not affected in the Fgfr2 cKO embryos. Although
we cannot exclude that FGFR2 might control the proliferation of
migrating RG/BG precursors, including those generating the
prospective BG cells [13], FGFR2-mediated signaling is unlikely to
control the prenatal proliferation of VZ progenitors for several
reasons: 1) Fgfr2 is not transcribed at detectable levels in the
cerebellar VZ throughout embryonic development; 2) PCs are
born at E10-13 in the mouse [1,60], long before Fgfr2 expression
initiates in the CbA (after E14.5); 3) The onset of Fgfr2
transcription in the CbA coincides with the peak of BG radial
migration toward the PCL at E15 in the mouse [13].
In contrast to the hGFAP-Cre;Fgfr1f/f;Fgfr2f/f [21] and Nestin-
Cre;Fgf9flox [20] mice, we did not detect any defects in GCP
numbers and proliferation in our Fgfr2 cKO mice. This is
consistent with the lack of Fgfr2 transcription in the EGL of the
wild-type embryo, and coincides with an ectopic activation of FGF
signaling (assessed by Etv5 expression) in the anterior EGL of the
Fgfr2 cKO embryos. Notably, the ectopic Etv5-expressing cells did
not overlap with the ectopically positioned Tnc+ BG cells in this
region of the mutant CbA. This finding suggests either that the
ectopic Etv5-expressing cells derived from the Etv5+ posterior EGL
and failed to downregulate the expression of Etv5 during their
tangential migration towards the anterior (rostral) EGL, or that
FGF signaling was ectopically activated in these cells by an
unknown, non-cell-autonomous mechanism in the absence of
Fgfr2. Furthermore, PCs were ectopically positioned within the GL
and GCs ‘‘protruded’’ into the PCL in the anterior lobules of the
adult Fgfr2 cKO cerebellum. The apparently normal alignment of
Glast+ RG fibers in the CbA of the mutant embryos suggests that
these are most likely secondary phenotypes appearing during
postnatal cerebellar development in the Fgfr2 cKO mice. The
disruption of the Blbp+ and Gfap+ BG fiber scaffold in the mutant
cerebellum might thus lead to an aberrant alignment of single PCs
within the PCL, and to the blocked migration of GCs along these
fibers through the PCL into the GL.
Incomplete penetrance and Fgfr1 as a genetic modifier of
the Fgfr2 cKO cerebellar phenotype
The cerebellar defects of the Fgfr2 cKO mice are not completely
penetrant and may have been missed inadvertently in previous
analyses of Fgfr2 single mutant mice [20,21]. Because cerebellar
phenotypes are particularly sensitive to genetic backgrounds [61],
it is very likely that the incomplete penetrance of the Fgfr2 cKO
cerebellar phenotype is due to genetic modifiers in the mixed
genetic background of our mice [62]. Indeed, the transcription of
Fgfr1 also appeared to be partially decreased in the CbA of the
affected Fgfr2 cKO embryos. As this was also true for regions
within the CbA where Fgfr2 is not expressed at high levels or in
many cells (such as the posterior CbA/PCL), the reduced
expression of Fgfr1 might be one genetic modifier in these mice.
Alternatively, the loss of FGFR2 function might affect the
transcription of Fgfr1 cell-autonomously or non-cell-autonomously
by yet unknown mechanism(s) in the developing CbA. Another
reason for the different cerebellar phenotypic outcomes of our
Fgfr2 cKO and the previously generated conditional Fgfr2 mutant
mice might be the different gene targeting strategies used for
generating these mice [27,63], although they should all result in
the absence of a functional FGFR2 receptor in the developing
CbA.
FGF9/FGFR2-mediated signaling might act as a positioning
cue for migrating BG cells
BG cells were located ectopically in the anterior EGL/ML of
the Fgfr2 cKO cerebella, indicating that FGFR2 signaling is
necessary for their proper positioning within the PCL. The radial
migration of BG precursors and cells from the VZ toward the PCL
starts at ,E14 and reaches a peak between E15–16 in the mouse
[13,36], the time interval when Fgfr2 transcription initiates in the
developing CbA. SHH secreted from PCs is a potent chemo-
attractant for BG cells that strongly promotes their migration [15].
The normal transcription of Shh in PCs of the mutant CbA
suggests that this guidance cue is not affected in the Fgfr2 cKO
embryos. The migration of BG cells, however, must be inhibited
once these cells have reached their final destination in the PCL to
prevent their ectopic positioning beyond this layer [13]. We
therefore hypothesized that an FGF signal emitted from the EGL
and/or PCL might provide such a ‘‘stop signal’’ to migrating BG
cells. One potential candidate was FGF9 expressed in GCPs and
PCs and required for the proper positioning of BG cells in the PCL
[19,20], although other FGFs expressed within the EGL (FGF1/
10) or PCL (FGF4/15) [19] might have a similar function. The
outward migration of RG/BG precursors/cells from CbA
microexplants was indeed inhibited after FGF9 treatment of these
explants, whereas FGFR blockade promoted the outward migra-
tion of RG/BG precursors/cells for longer distances from the
explants. These results strongly suggest that RG/BG precursors/
cells fail to detect the probably concentration-dependent FGF9
‘‘stop signal’’ from the EGL/PCs in the absence of FGFR2-
mediated signaling, and therefore migrate beyond their normal
position within the PCL. Altogether, our findings thus reveal the
specific pro-differentiation, anti-apoptotic and cell positioning
functions of FGFR2-mediated signaling in RG/BG precursors/
cells during cerebellar development in the mouse, and might
provide new mechanistic insights to the pathogenesis of cerebellar
ataxias.
Supporting Information
File S1 Table S1. Locomotor behaviors of control and
Fgfr2 cKO mice. 12 weeks old male Fgfr2lox/lox (control, n = 15)
and Nestin-Cre;Fgfr2lox/lox (Fgfr2 cKO, n= 12) mice were tested in
the modified hole board (mHB) for horizontal and vertical
locomotor abilities. Motor coordination and balance was assessed
with the rotating rod apparatus (Rotarod). All values given are
mean 6 s.e.m. Table S2. Average proportion of Ccnd1+/
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Pax62 RG/BG precursors/cells among the total number
of migrating Ccnd1+ and/or Pax6+ cells in each 50-mm
bin in control-, FGF9- or SU5402-treated microexplant
cultures. Values represent the average proportion of Ccnd1+/
Pax62 RG/BG precursors/cells among the total number of
migrating Ccnd1+ and/or Pax6+ cells in each 50-mm bin (distance
migrated from the border of the microexplant) and for each
treatment, and the 95% confidence interval estimated with a
logistic model (in 8 bins and 3 treatments: total cells migrated:
1168, among them RG/BG precursors/cells: 146). Figure S1.
Correlation of locomotor and cerebellar phenotypes in
adult Fgfr2 cKO mice. (A) Rotarod performance (latencies to
fall) of 15 control and 12 Fgfr2 cKO males. Highlighted in red are
the control male with the shortest latency to fall (16 sec, ID
30064154), and two Fgfr2 cKO males with the longest (140 sec, ID
30064156) and shortest (25 sec, ID 30064164) latencies to fall. (B–
G) Sagittal cerebellar sections from the adult males highlighted in
red in (A), counterstained with DAPI (B,D,F) or immunostained
for Calb1 (C,E,G). Note the severe cerebellar defects in the ID
30064164 Fgfr2 cKO male with the shortest latency to fall from the
Rotarod (F,G). I-X, lobuli of the adult cerebellum. Scale bar (B):
500 mm. Figure S2. The ventral mid-/hindbrain region is
not affected in Fgfr2 cKO mice. (A–F) Sagittal views of the
ventral MHR from adult control (A,C,E) and Fgfr2 cKO mice
(B,D,F), hybridized with riboprobes for Tyrosine hydroxylase (Th;
the rate-limiting enzyme for dopamine and noradrenaline
synthesis) (A,B), the Serotonin transporter (Sert, also known as
Slc6a4, expressed on serotonergic neurons) (C,D) and the vesicular
Acetylcholine transporter (VAChT, also known as Slc18a3,
expressed in cholinergic neurons) (E,F). Gross anatomical
alterations of these neuronal populations were not detected in
the Fgfr2 cKO mice. DR, dorsal raphe nucleus; LC, locus ceruleus;
LDTg, laterodorsal tegmental nucleus; RF, reticular formation
(brainstem); SNc, substantia nigra pars compacta; VTA, ventral
tegmental area. Scale bar (A): 500 mm. Figure S3. Fgfr
expression in the developing murine mid-/hindbrain
region. (A–R) Representative brightfield (A–C,G–I,M–O) and
darkfield (D–F,J–L,P–R) views of the mid-/hindbrain region on
cresyl-violet-stained midsagittal sections from wild-type (CD-1)
mouse embryos at E14.5 (A–F; n= 5 embryos), E16.5 (G–L; n= 5
embryos), and E18.5 (M–R; n= 6 embryos), hybridized with
radioactive Fgfr1 (A,D,G,J,M,P), Fgfr2 (B,E,H,K,N,Q) and Fgfr3
(C,F,I,L,O,R) riboprobes. CbA, cerebellar anlage; ChPl, choroid
plexus; EGL, external granular layer; IC, inferior colliculus; PCL,
Purkinje cell layer; rH, rostral hindbrain; rl, rhombic lip; Tg,
tegmentum; VZ, cerebellar ventricular zone. Scale bar (C):
200 mm. Figure S4. Disruption of the anterior PCL but
apparently normal RG scaffold in the E17.5 Fgfr2 cKO
CbA. (A–L) Representative confocal overviews (A,B,E–L) and
close-up views (C,D) of the anterior CbA on sagittal sections from
control (A,C,E,G,I,K) and Fgfr2 cKO (B,D,F,H,J,L) embryos at
E17.5 (n = 1 embryo/genotype), immunostained for Pax6 (cyan/
green in A–D; a marker for GCPs) and Calb1 (red in A–D; a
marker for PCs), or Ccnd1 (cyan/green in E–H; a marker for
cycling GCPs and RG/BG precursors/cells) and Glast (red in
E,F,I,J; a marker for RG/BG fibers), and counterstained with
DAPI (blue in A–F,K,L; a nuclear marker). (C,D) are close-up
views of the boxed areas in (A,B). (G–L) are single color channel
views of (E,F), respectively. Yellow arrowheads in (D) delimit the
lacking Calb1+ anterior PCL in the mutant embryos, and in (F)
point at ectopically located Ccnd1+ RG/BG precursors within the
mutant cerebellar VZ. White arrowheads in (F,H) delimit the
distorted Ccnd1+ anterior outer EGL in the mutant embryos.
EGL, external granular layer; PCL, Purkinje cell layer. Scale bars:
100 mm (A); 30 mm (C). Figure S5. SHH signaling does not
appear to be affected in the CbA of Fgfr2 cKO embryos.
(A–H) Representative sagittal darkfield (A,B) and brightfield (C–H)
views of the CbA in E16.5 (A–D; n= 5 embryos/genotype) and
E18.5 (E–H; n= 4 embryos/genotype) control (A,C,E,G) and Fgfr2
cKO (B,D,F,H) embryos, hybridized with riboprobes for Shh
(A,B,E,F) and Ptch1 (C,D,G,H). Red arrowheads in (F) delimit the
lacking Shh+ anterior PCL in the mutant embryos. EGL, external
granular layer; PCL, Purkinje cell layer. Scale bar (A): 100 mm.
(PDF)
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